Hongshan is a company that appears to specialize in the production and sale of traditional Chinese herbal medicines and health products. They emphasize a commitment to quality, tradition, and the use of natural ingredients in their product offerings.

Hongshan

Dayone Capital is an investor focusing on selective areas within the consumer goods industry, committed to value creation.

日初资本 Dayone Capital

HongShan is a leading venture capital and private equity firm investing across technology, healthcare and consumer sectors. Since 2005, HongShan has been fostering entrepreneurship and innovation, backing more than 1,500 companies around the globe with transformative technologies, disruptive business models and high-growth potential. To date, more than 160 HongShan portfolio companies have listed on public stock exchanges, while over 140 private portfolio companies have reached unicorn status.

Metric
Company Name	Hongshan	日初资本 Dayone Capital
Symbol
MSH ID	COM:HONGSHAN	COM:DAYONECAP
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance
Industry	Pharmaceuticals, Biotechnology & Life Sciences	Investment Management
Country	CN	CN
Stage
Employee Count	337
Website	hongshan.com	dayonecap.com
LinkedIn	hong-shan	dayonecapital
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	97.17
28-Day Growth Score	74.92
90-Day Growth Score	72.57
365-Day Growth Score	34.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:HONGSHAN

Hongshan

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue